Journal
NEUROBIOLOGY OF AGING
Volume 28, Issue 10, Pages 1493-1506Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2006.06.023
Keywords
Alzheimer's disease; beta-amyloid; oldest old; trisomy 21
Categories
Funding
- NIA NIH HHS [AG21912, P50 AG016573, R01 AG021055, R01 AG021912, P50 AG 05136-21, P50 AG005136, P50 AG16573, AG21055] Funding Source: Medline
Ask authors/readers for more resources
Aged individuals with Down syndrome (DS) develop Alzheimer's disease (AD) neuropathology by the age of 40 years. The purpose of the current study was to measure age-associated changes in APP processing in 36 individuals with DS (5 months-69 years) and in 26 controls (5 months-100 years). Alpha-secretase significantly decreased with age in DS, particularly in cases over the age of 40 years and was stable in controls. The levels of C-terminal fragments of APP reflecting alpha-secretase processing (CTF-alpha) decreased with age in both groups. In both groups, there was significant increase in beta-secretase activity with age. CTF-beta remained constant with age in controls suggesting compensatory increases in turnover/clearance mechanisms. In DS, young individuals had the lowest CTF-beta levels that may reflect rapid conversion of beta-amyloid (A beta) to soluble pools or efficient CTF-beta clearance mechanisms. Treatments to slow or prevent AD in the general population targeting secretase activity may be more efficacious in adults with DS if combined with approaches that enhance AP degradation and clearance. (c) 2006 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available